PBMares Wealth Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
PBMares Wealth Management's PFE Position: Q3 2025 in Review
PBMares Wealth Management increased its Pfizer (PFE) stake by 4.3% in Q3 2025, buying an estimated $11.6K and bringing the position to 11,547 shares worth $294K. The position accounts for 0.05% of the portfolio, ranked #155.
PBMares Wealth Management first reported a position in PFE in Q4 2019 and has held it in 24 quarters since. The position peaked at $1.35M in Q4 2021. 2,811 funds tracked by Wall St. Rank hold PFE as of Q3 2025.
- PBMares Wealth Management held 11,547 shares of Pfizer worth $294K as of Q3 2025.
- PBMares Wealth Management bought 471 Pfizer shares in Q3 2025, an estimated $11.6K.
- Pfizer made up 0.05% of PBMares Wealth Management's portfolio in Q3 2025, its #155 holding.
- PBMares Wealth Management first reported a position in Pfizer in Q4 2019 and has held it in 24 quarters since.
- PBMares Wealth Management's Pfizer position peaked at $1.35M in Q4 2021.
- 2,811 funds tracked by Wall St. Rank held Pfizer as of Q3 2025.
Based on PBMares Wealth Management's 13F filing for Q3 2025, filed 27 Oct 2025.